Syncytium formation amplifies apoptotic signals: A new view on apoptosis in HIV infection in vitro

Virology

Volumn 282, Issue 1, 2001, Pages 48-55

  Scheller, Carsten ^a   Jassoy, Christian ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Apoptosis; CD4; Envelope glycoprotein; HIV; Measles virus; Syncytium; T20

Indexed keywords

VIRUS GLYCOPROTEIN;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL FUSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SYNCYTIUM; VIRUS PATHOGENESIS;

MEASLES VIRUS;

EID: 0035970310     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0811     Document Type: Article

References (46)

1. Vaccinia virus-induced apoptosis in immature B lymphocytes: Role of cellular Bcl-2
2. Caspase-dependent apoptosis of cells expressing the chemokine receptor CXCR4 is induced by cell membrane-associated human immunodeficiency virus type 1 envelope glycoprotein (gp120)
3. Role of CXCR4 in HIV-1-induced apoptosis of cells with a CD4+, CXCR4+ phenotype
4. The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis
5. The implication of the chemokine receptor CXCR4 in HIV-1 envelope protein-induced apoptosis is independent of the G protein-mediated signalling
6. Enhancement of HIV-1-induced syncytium formation in T cells by the tyrosyl kinase p56lck
7. Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1
8. HIV entry and its inhibition
9. A molecurar clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: Implication for viral fusion
10. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity
11. Productive infection and subsequent interaction of CD4-gp120 at the cellular membrane is required for HIV-induced apoptosis of CD4+ T cells
12. HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p56lck
13. Biological and immunological properties of human immunodeficiency virus type 1 envelope glycoprotein: Analysis of proteins with truncations and deletions expressed by recombinant vaccinia viruses
14. Apoptosis as a cause of death in measles virus-infected cells
15. Characterization of a continuous T-cell line susceptible to the cytopathic effects of the acquired immunodeficiency syndrome (AIDS)-associated retrovirus
16. Apoptosis induced by HIV infection in H9 T cells is bfocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist
17. An anti-CD4 (CDR3-loop) monoclonal antibody inhibits human immunodeficiency virus type 1 envelope glycoprotein-induced apoptosis
18. Inhibition of CD95 (Fas/Apo1)-mediated apoptosis by vaccinia virus WR
19. Biochemical characterization of the protein activity responsible for high molecular weight DNA fragmentation during drug-induced apoptosis
20. Rhodamine 110-linked amino acids and peptides as substrates to measure caspase activity upon apoptosis induction in intact cells
21. Replication of feline syncytial virus in feline T-lymphoblastoid cells and induction of apoptosis in the cells
22. Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1 beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1 beta-induced fever
23. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells
24. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry
25. The difference in gp160 and gp120 of HIV type 1 in the induction of CD4 downregulation preceding single-cell killing
26. A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis
27. The cytopathic effect of HIV is associated with apoptosis
28. Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells
29. Induction of apoptosis in uninfected lymphocytes by HIV-1 Tat protein
30. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein
31. AIDS retrovirus induced cytopathology: Giant cell formation and involvement of CD4 antigen
32. Apoptosis induced in CD4+ cells expressing gp160 of human immunodeficiency virus type 1
33. Rapid induction of apoptosis by cell-to-cell transmission of human immunodeficiency virus type 1
34. CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells
35. Apoptotic cell death upon contact of CD4+ T lymphocytes with HIV glycoprotein-expressing cells is mediated by caspases but bypasses CD95 (Fas/Apo-1) and TNF receptor 1
36. Nef protein of HIV-1 induced apoptotic cytolysis of murine lymphoid cells independently of CD95 (Fas) and its suppression by serine/threonine protein kinase inhibitors
37. Effects of human immunedeficiency virus type 1 infection on programmed cell death in the presence or absence of Bcl-2
38. HIV type 1 Tat protein induces apoptosis and death in Jurkat cells
39. Apoptosis induced by a post-binding step of vaccinia virus entry into Chinese hamster ovary cells
40. The CD46 transmembrane domain is required for efficient formation of measles-virus-mediated syncytium
41. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity
42. A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion
43. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1
44. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition
45. Measles virus: Both the haemagglutinin and fusion glycoproteins are required for fusion